For research use only. Not for therapeutic Use.
Ozagrel sodium (OKY-046 sodium) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel sodium is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1].
Catalog Number | I008529 |
CAS Number | 189224-26-8 |
Synonyms | sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate |
Molecular Formula | C13H11N2NaO2 |
Purity | ≥95% |
InChI | InChI=1S/C13H12N2O2.Na/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;/h1-8,10H,9H2,(H,16,17);/q;+1/p-1/b6-5+; |
InChIKey | NCNYJCOBUTXCBR-IPZCTEOASA-M |
SMILES | C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)[O-].[Na+] |
Reference | [1]. Max Seidy Saito, et al. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1591-601. |